Sai Life Sciences IPO Financials
The Sai Life Sciences IPO provide an overview of the company's performance over the previous financial periods. Investors can evaluate key financial metrics such as assets, revenue, profit after tax (PAT), net worth, reserves & surplus, and total borrowings to assess the company's financial strength, profitability, and long-term growth potential before investing in the IPO.
As of 30 Sep 2024, Sai Life Sciences Limited reported assets of ₹2,476.78 crore, revenue of ₹693.35 crore, and a profit after tax (PAT) of ₹28.01 crore. The company had a net worth of ₹1,044.75 crore and reserves & surplus of ₹855.69 crore, and total borrowings are 764.49 crore.
Revenue increased by 115.51% in 31 Mar 2024 and decreased by 16.67% in 31 Mar 2023 and decreased by 27.90% in 31 Mar 2022, while Profit After Tax (PAT) grew by 195.64% in 31 Mar 2024 and declined by 87.94% in 31 Mar 2023 and declined by 37.64% in 31 Mar 2022, respectively.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Sai Life Sciences Limited Financials (₹ in Crores)
| Particular | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 2476.78 | 2275.14 | 2186.65 | 2164.23 |
| Revenue | 693.35 | 1494.27 | 1245.11 | 897.74 |
| Profit After Tax | 28.01 | 82.81 | 9.99 | 6.23 |
| Net Worth | 1044.75 | 974.34 | 887.29 | 877.76 |
| Reserve & Surplus | 855.69 | 953.99 | 867.43 | 859.17 |
| Total Borrowings | 764.49 | 710.16 | 699.23 | 751.32 |
EPS Pre
4.34%
EPS Post
2.69%
P/E Pre
126.42
P/E (Post Issue)
203.82x
Company Financial Information
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Revenue of Sai Life Sciences Limited?
Sai Life Sciences Limited reported revenue of ₹693.35 crore as of 30 Sep 2024. Revenue figures from the Sai Life Sciences IPO provide insights into sales growth, market demand, and business scalability.
What is the Profit After Tax (PAT) of Sai Life Sciences Limited?
Sai Life Sciences Limited reported a Profit After Tax (PAT) of ₹28.01 crore as of 30 Sep 2024. PAT represents the company's net profit after deducting all operating expenses, interest, taxes, and other applicable charges, making it a key indicator of overall profitability.
What is the PE Ratio of Sai Life Sciences Limited?
Sai Life Sciences Limited has a Price-to-Earnings (P/E) ratio of 126.42x based on the IPO issue price. The P/E ratio compares the company's share price with its earnings per share (EPS) and is a commonly used valuation metric to assess whether a stock is fairly valued relative to its earnings and industry peers.